ArticleBiotechnology letters2023

Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer.

Maryam Ahmadzadeh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.